The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

Dividends

0.44%Dividend Yield

Jan 26

$0.14

Jan 22

Dec 21

$0.11

Dec 20

$0.05

10Y Growth

N/A

5Y Growth

3.95%

3Y Growth

N/A

1Y Growth

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HELX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

ARK Genomic Revolution

ARKG

Mkt Cap0

ARK Genomic Revolution ETF focuses on companies likely to benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments, genomics, and molecular diagnostics, directly competing with HELX's investment focus.

Global X Genomics & Biotechnology

GNOM

Mkt Cap0

Global X Genomics & Biotechnology ETF invests in companies involved in genomics and biotechnology, offering direct competition to HELX by targeting similar advancements and technologies in the genomic space.

iShares Genomics Immunology and Healthcare

IDNA

Mkt Cap0

iShares Genomics Immunology and Healthcare ETF targets companies in the genomics, immunology, and bioengineering sectors, competing with HELX by investing in the rapidly evolving genomics industry.

Principal Healthcare Innovators

BTEC

Mkt Cap0

Principal Healthcare Innovators Index ETF focuses on companies that are leading the charge in healthcare innovation, including genomics and biotechnology, positioning it as a competitor to HELX.

Invesco Biotechnology & Genome

PBE

Mkt Cap0

Invesco Dynamic Biotechnology & Genome ETF invests in companies that are principally engaged in the research, development, manufacture, and distribution of various biotechnological products, therapies, and services, including genomic research, competing directly with HELX's focus.

VanEck Biotech

BBH

Mkt Cap0

VanEck Vectors Biotech ETF includes holdings in biotechnology companies involved in the use of biological and genetic knowledge to develop new therapies and products, competing with HELX in the genomic advancements space.

First Trust NYSE Arca Biotechnology Index Fund

FBT

Mkt Cap0

First Trust NYSE Arca Biotechnology Index Fund is composed of firms in the biotechnology sector, which includes genomic research and development, making it a competitor to HELX.

iShares Biotechnology

IBB

Mkt Cap0

iShares Biotechnology ETF offers exposure to U.S. biotechnology and pharmaceutical companies, which includes companies involved in genomic and genetic research, competing with HELX's investment strategy.

State Street SPDR S&P Biotech

XBI

Mkt Cap0

SPDR S&P Biotech ETF provides exposure to the biotech sector, including genomic research and development companies, making it a competitor to HELX.

ALPS Medical Breakthroughs

SBIO

Mkt Cap0

ALPS Medical Breakthroughs ETF invests in companies with one or more drugs in Phase II or Phase III FDA clinical trials, which often include genomic and genetic research companies, positioning it as a competitor to HELX.

Holdings

Regions

Sectors

About

The fund seeks capital appreciation by investing in equity securities inside and outside of the United States, including developing or emerging markets. The fund invests in companies that are relevant to its investment theme of genomic advancements that the investment manager believes are substantially focused on/or are expected to substantially benefit from extending and enhancing the quality of human and other life (e.g., animals) by incorporating technological and scientific developments, improvements and advancements in the field of genomics into their business.

CEO

Country

ISIN

US35473P5200

Listings

0 Comments

Share your thoughts

FAQ

What is Franklin Genomic Advancements stock price today?▼

The current price of HELX is $32.6 USD — it has decreased by -2.92% in the past 24 hours. Watch Franklin Genomic Advancements stock price performance more closely on the chart.

What is Franklin Genomic Advancements stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Franklin Genomic Advancements stocks are traded under the ticker HELX.

Is Franklin Genomic Advancements stock price growing?▼

HELX stock has fallen by -2.42% compared to the previous week, the month change is a -2.25% fall, over the last year Franklin Genomic Advancements has showed a +28.75% increase.

Does Franklin Genomic Advancements pay dividends?▼

Yes, HELX dividends are paid annual. The last dividend per share was 0.14 USD. As of today, Dividend Yield (FWD)% is 0.44%.

When did Franklin Genomic Advancements complete a stock split?▼

Franklin Genomic Advancements has not had any recent stock splits.